49
Views
36
CrossRef citations to date
0
Altmetric
Case Report

Septic arthritis due to Salmonella enteritidis associated with infliximab use

, , , , , & show all
Pages 304-306 | Received 21 Sep 2004, Accepted 30 Sep 2004, Published online: 08 Jul 2009

References

  • Maini R, St Clair WE, Breedveld F, Furst D, Kalden J, Weisman M, et al. for the ATTRACT Study Group. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. Lancet 1999;354:1932–9.
  • Day R. Adverse reactions to TNF-α inhibitors in rheumatoid arthritis. Lancet 2002;359:540–1.
  • Krumme B, Conca W, Balle C, Peter HH, Schollmeyer P. Salmonella arthritis in a patient with severe lupus nephritis and thalassaemia minor. Nephron 1995;7:465–7.
  • Miller SI, Pegues DA. Salmonella (including Salmonella typhi). In: Mandell, editor. Principles and Practice of Infectious Disease, 5th edn. Churchill Livingstone Inc; 1995. p. 2345–63.
  • Dinarello CA. Anti-cytokine therapeutics and infections. Vaccine 2003;21(Suppl 2):S2–34.
  • Bresnihan B, Cunnane G. Infection complications associated with the use of biological agents. Rheum Dis Clin North Amer 2003;29:185–202.
  • Netea MG, Radstake T, Joosten LA, van der Meer JW, Barrera P, Kullberg BJ. Salmonella septicaemia in rheumatoid arthritis patients receiving anti-tumour necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression. Arthritis Rheum 2003;48: 1853–7.
  • Ang HT, Helfgott S. Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumour necrosis factor-alpha antagonists in patients with rheumatoid arthritis? J Rheumatol 2003;30:2315–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.